Imaging bioluminescence by detecting localized haemodynamic contrast from photosensitized vasculature.
Robert OhlendorfNan LiValerie Doan Phi VanMiriam SchwalmYuting KeMiranda DawsonYing JiangSayani DasBrenna StallingsWen Ting ZhengAlan JasanoffPublished in: Nature biomedical engineering (2024)
Bioluminescent probes are widely used to monitor biomedically relevant processes and cellular targets in living animals. However, the absorption and scattering of visible light by tissue drastically limit the depth and resolution of the detection of luminescence. Here we show that bioluminescent sources can be detected with magnetic resonance imaging by leveraging the light-mediated activation of vascular cells expressing a photosensitive bacterial enzyme that causes the conversion of bioluminescent emission into local changes in haemodynamic contrast. In the brains of rats with photosensitized vasculature, we used magnetic resonance imaging to volumetrically map bioluminescent xenografts and cell populations virally transduced to express luciferase. Detecting bioluminescence-induced haemodynamic signals from photosensitized vasculature will extend the applications of bioluminescent probes.
Keyphrases
- magnetic resonance imaging
- contrast enhanced
- visible light
- magnetic resonance
- energy transfer
- single molecule
- fluorescence imaging
- small molecule
- computed tomography
- induced apoptosis
- high resolution
- living cells
- single cell
- cell therapy
- stem cells
- high glucose
- quantum dots
- diabetic rats
- diffusion weighted imaging
- mass spectrometry
- endothelial cells
- photodynamic therapy
- label free
- monte carlo